Literature DB >> 31005759

Differential diagnosis of multiple system atrophy with predominant parkinsonism and Parkinson's disease using neural networks.

Mitsunori Tsuda1, Shingo Asano2, Yasushi Kato3, Katsumasa Murai4, Masao Miyazaki3.   

Abstract

Differential diagnosis between Parkinson's disease (PD) and atypical parkinsonism, such as multiple system atrophy (MSA), can be difficult, especially in the early stages of the disease. Deep learning using neural networks (NNs) makes possible the prediction of the diagnosis using various types of biomarkers, unlike conventional linear statistics. We aimed to differentiate the Parkinson's variant of MSA (MSA-P) from PD both in the early stages by clinical utilization of NN analyses before the hot cross-bun and putaminal rim imaging features of MSA appeared. Analysis by NN involved the data of voxel-based morphometry (VBM) that indicate morphological changes and magnetic resonance spectroscopy (MRS) that indicate qualitative changes. VBM analysis showed that compared with PD patients, MSA-P patients showed atrophy in the superior cerebellar peduncle, middle cerebellar peduncle, cerebellar hemisphere, pons, midbrain, and putamen, but not in the globus pallidus. Proton MRS on the globus pallidus in the diseased hemisphere, lacking atrophy as observed with VBM, revealed decreased neurons and gliosis in both groups. Clinical differentiation of MSA-P from PD using NN analysis, involved measuring the prediction potential using the area under the receiver operator characteristic (ROC) curves (AUC). Using both VBM and MRS data, NNs contributed adequately to the clinical diagnosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deep learning; Magnetic resonance spectroscopy; Multiple system atrophy; Neural network; Parkinson's disease; Voxel-based morphometry

Year:  2019        PMID: 31005759     DOI: 10.1016/j.jns.2019.04.014

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Hyperpolarized MRI, functional MRI, MR spectroscopy and CEST to provide metabolic information in vivo.

Authors:  Peter C M van Zijl; Kevin Brindle; Hanzhang Lu; Peter B Barker; Richard Edden; Nirbhay Yadav; Linda Knutsson
Journal:  Curr Opin Chem Biol       Date:  2021-07-20       Impact factor: 8.972

2.  Discriminative pattern of reduced cerebral blood flow in Parkinson's disease and Parkinsonism-Plus syndrome: an ASL-MRI study.

Authors:  Lina Cheng; Xiaoyan Wu; Ruomi Guo; Yuzhou Wang; Wensheng Wang; Peng He; Hanbo Lin; Jun Shen
Journal:  BMC Med Imaging       Date:  2020-07-13       Impact factor: 1.930

3.  Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study.

Authors:  Tao Yue; Hui Lu; Xiao-Mei Yao; Xia Du; Ling-Ling Wang; Dan-Dan Guo; Yi-Ming Liu
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

Review 4.  Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.

Authors:  Usman Saeed; Anthony E Lang; Mario Masellis
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

5.  Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy.

Authors:  S Ponticorvo; R Manara; M C Russillo; R Erro; M Picillo; G Di Salle; F Di Salle; P Barone; F Esposito; M T Pellecchia
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

6.  Predicting Parkinson's Disease Progression: Evaluation of Ensemble Methods in Machine Learning.

Authors:  Mehrbakhsh Nilashi; Rabab Ali Abumalloh; Behrouz Minaei-Bidgoli; Sarminah Samad; Muhammed Yousoof Ismail; Ashwaq Alhargan; Waleed Abdu Zogaan
Journal:  J Healthc Eng       Date:  2022-02-03       Impact factor: 2.682

7.  Differentiation of Parkinson's disease and Parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging.

Authors:  Qingguo Ren; Yihua Wang; Xiaona Xia; Jianyuan Zhang; Cuiping Zhao; Xiangshui Meng
Journal:  Front Hum Neurosci       Date:  2022-08-02       Impact factor: 3.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.